Crinetics presents phase II data from ACROBAT Edge and ACROBAT Evolve studies of paltusotine Oct. 27, 2020
Intellia receives authorization to initiate first-in-human study of NTLA-2001 in the U.K. Oct. 20, 2020
RSS